Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 10,033

Document Document Title
WO/2020/187865A1
The invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.  
WO/2020/157652A3
This invention relates to compounds of Formula (I), and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein R1, R2 and R3 are as defined herein. The invention further relates to phar...  
WO/2020/180127A1
The present invention relates to a novel compound having excellent electron transport ability and luminescence, and an organic electroluminescent device which comprises same in one or more organic layers and thus has improved characteris...  
WO/2020/169804A1
Compounds of formula (I), wherein A, Z, E, R1, R2, m and n have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.  
WO/2020/150417A3
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes...  
WO/2020/167976A1
Described herein are compounds that regulate pyruvate kinase activity, pharmaceutical compositions and methods of use thereof. These compounds are represented by Formula (I) wherein R2, L1-L2, U1-U7, m, ring A, and Q are as defined herein.  
WO/2020/167984A1
Provided herein are compounds of Formulae (I) and (II), or pharmaceutically acceptable salts of the foregoing, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compoun...  
WO/2020/161209A1
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.  
WO/2020/161208A1
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.  
WO/2020/051207A3
The disclosure relates to aryl hydrocarbon receptor antagonists as well as methods of modulating aryl hydrocarbon receptor activity and expanding hematopoietic stem cells by culturing hematopoietic stem or progenitor cells in the presenc...  
WO/2020/157652A2
This invention relates to compounds of Formula (I), and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein R1, R2 and R3 are as defined herein. The invention further relates to phar...  
WO/2020/158870A1
The purpose in one embodiment of the present invention is to provide a therapeutic for Parkinson's disease, etc. A compound represented by formulas (1), (2), or (8) or a pharmacologically acceptable salt thereof can be used in the treatm...  
WO/2020/156243A1
Provided is a compound for use as an inhibitor of Src homology region 2-containing protein tyrosine phosphatase 2 (SHP2) (as represented by formula I), and pharmaceutical composition and preparation method thereof, and use thereof in the...  
WO/2020/152132A1
The invention relates to thiazolopyridine derivatives which fall under the general formula I, (I) and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and ...  
WO/2020/153432A1
The present invention addresses the problem of providing a compound that is useful as an active ingredient for preventing and treating inflammatory diseases and that has a chemical structure to function as a specific antedrug having an e...  
WO/2020/153431A1
The present invention addresses the problem of providing a compound that is useful as an active ingredient for preventing and treating inflammatory diseases and that has a chemical structure to function as a specific antedrug having an e...  
WO/2020/153433A1
The present invention addresses the problem of providing a compound that is useful as an active ingredient for preventing and treating inflammatory diseases and that has a specific chemical structure having an effect of activating SIRT6....  
WO/2020/150417A2
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes...  
WO/2020/147802A1
Provided are compounds represented by Formula (I-A) and the pharmaceutically acceptable salts and solvates thereof, wherein R8, R9a, R9b, R9c, R9d, X, Y, Z, Z1, W, and (aa) are as defined as set forth in the specification. Provided are a...  
WO/2020/143798A1
The invention relates to an internal cyclic sulphiamidine amide-aryl amide compound and a use thereof for treating hepatitis B. Specifically, disclosed is a compound that may act as an HBV replication inhibitor and that has a structure r...  
WO/2020/141478A1
The present invention provides novel thiazolyl peptide compounds and their pharmaceutically acceptable salts either alone or in combinations with Rifampicin, Amikacin and Clarithromycin against infections caused by Nontuberculous mycobac...  
WO/2020/138015A1
The present invention provides: a novel compound that is useful for treating or preventing infections associated with viruses belonging to the subfamily Pneumovirinae, including respiratory syncytial virus (RSV), and that has an anti-RSV...  
WO/2020/135439A1
A deuterated dihydropyrimidine compound and use thereof as a drug, especially as a drug for treating and preventing hepatitis B. In particular, the present invention relates to a compound represented by general formula (I) or (Ia) or a s...  
WO/2020/125729A1
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.  
WO/2020/126591A1
The present invention relates to substituted pyrimidinium compounds of formula (I), to the stereoisomers, salts, tautomers and N-oxides thereof and to compositions comprising such compounds. The invention also relates to methods and uses...  
WO/2020/127960A1
The present invention relates to disubstituted alkyne derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.  
WO/2020/127735A1
This invention is directed to improved processes for the preparation of (2-amino-4-[6-(4-fluorophenyl)-2-[(4-methyl-1-piperazinyl)me thyl]imidazo[2,1-b]thiazol-5-yl]-pyrimidine of Formula (I).  
WO/2020/127765A1
The present invention is directed to crystalline phosphate salts of 5,6-diarylimidazo[2,1-b][1,3]thiazoles of Formula (I) or a solvate or hydrate thereof, wherein R = NH2 or H; A = CH or N; R' = CH2-1-Me-piperazin-4-yl or CH2NMe2; X = F,...  
WO/2020/125730A1
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.  
WO/2020/130681A1
The present invention relates to a novel compound and an organic electroluminescent device comprising same. As the compound according to the present invention is used in an organic material layer of an organic electroluminescent device, ...  
WO/2020/132381A1
The present invention relates to co-crystals of the compound of formula (I), wherein the co-former molecule is succinic acid or citric acid, processes for the preparation of the co-crystal, pharmaceutical compositions thereof, and method...  
WO/2020/123850A1
The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of adm...  
WO/2020/121823A1
The present invention addresses the problem of providing: a liquid crystal composition which is to be used in an active drive display element and improves chromatic dispersion properties; a display element which uses said liquid crystal ...  
WO/2020/111613A1
The present invention provides a novel compound and an organic light-emitting diode using same.  
WO/2020/111602A1
The present invention provides a novel compound and an organic light-emitting element using same.  
WO/2020/110056A1
The invention relates to compounds of Formula (I), (Ia), (Ib), (II) or (III), salts thereof, pharmaceutical compositions thereof, as well as therapeutic methods of treatment and prevention.  
WO/2020/111586A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2020/111584A1
The present invention provides a novel compound and an organic light emitting diode using same.  
WO/2020/111601A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2020/111780A1
The present invention provides a novel compound and an organic light emitting device using same.  
WO/2020/111585A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2020/108579A1
The present invention relates to an amino-substituted pyridone derivative, a preparation method therefor, and a pharmaceutical use thereof. Specifically, disclosed are a compound of formula (I), or a pharmaceutically acceptable salt, a s...  
WO/2020/106736A1
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes...  
WO/2020/102857A1
Disclosed herein are methods for causing weight loss, for managing weight, and for suppressing an appetite for food in a subject, and methods for reducing the consumption of food by a subject by administering the compounds, or pharmaceut...  
WO/2020/101316A1
The present specification relates to a heterocyclic compound represented by chemical formula 1, and an organic light-emitting device comprising same.  
WO/2020/055725A4
Disclosed herein are novel methods of treating pain in a patient in need thereof by providing to the patient a selective dopamine D3 receptor antagonist/partial agonist which when used with an opioid analgesic, can mitigate the developme...  
WO/2020/096416A1
The present invention relates to a compound which inhibits the binding of Yes associated protein (YAP) and transcriptional enhancer associate domain (TEAD), a prodrug of same, a hydrate of same, a solvate of same or a pharmaceutically ac...  
WO/2020/097577A1
The disclosure is directed to compounds of Formula I (I) Pharmaceutical compositions comprising compounds of Formula I as well as methods of their use and preparation, are also described.  
WO/2020/096199A1
The present specification provides a compound of chemical formula 1 and an organic light emitting diode comprising same.  
WO/2020/090636A1
Provided are: a compound having excellent semiconductor characteristics; a method for producing the compound; an intermediate of the compound; a method for producing the intermediate; and an organic semiconductor material and an organic ...  

Matches 1 - 50 out of 10,033